Market Cap 8.52B
Revenue (ttm) 2.35B
Net Income (ttm) 128.37M
EPS (ttm) N/A
PE Ratio 313.08
Forward PE 715.62
Profit Margin 5.47%
Debt to Equity Ratio 0.00
Volume 16,473,700
Avg Vol 22,090,057
Day's Range N/A - N/A
Shares Out 231.46M
Stochastic %K 79%
Beta 2.35
Analysts Sell
Price Target $28.96

Company Profile

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health a...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 415 851 0195
Address:
2269 Chestnut Street, Suite 523, San Francisco, United States
JD101
JD101 Jul. 4 at 6:34 PM
0 · Reply
inquisitive1
inquisitive1 Jul. 4 at 6:12 PM
$HIMS Arrie, thanks for clarifying German market. We shall see what Monday brings here in the U.S.
0 · Reply
stockro1
stockro1 Jul. 4 at 2:28 PM
$IXHL The market has a habit of mispricing companies when the story changes faster than the valuation. I think that’s happening here. • Targeting one of the world’s largest unmet medical markets (Obstructive Sleep Apnoea) • Positive Phase 2 efficacy • Strong balance sheet, minimal debt • Multiple catalysts ahead • Small share count • Valuation that still looks modest if development succeeds This is now an execution story. Today’s valuation appears to price in far more failure than success. Watching for: ✔️ First patient dosed ✔️ Clinical progress ✔️ Institutional buying ✔️ Strategic partnerships The biggest gains often come before consensus catches up. Do your own research. $IXHL $VKTX $ALT $HIMS $LLY
3 · Reply
Arrie1982
Arrie1982 Jul. 4 at 11:36 AM
$HIMS this means 39 in usd, strong day in Europe 👌
0 · Reply
shwesdawg
shwesdawg Jul. 4 at 4:58 AM
$HIMS bodega by my house is selling peptides now 😂😂😂
1 · Reply
SocialYoutube
SocialYoutube Jul. 3 at 10:25 PM
$HIMS Been reading up on the cGMP validation process. You need to produce 3 consecutive batches (3-5 weeks per batch) and everything from software, hardware, ventilation, sensors, product, purity, safety, and data --- nothing can go wrong or you start all over. Then you have to wait to make sure that your product doesn't degrade while being stored over 1 month, 3 month, and 6 month time spans. Hims should be on track to supply their own compounding facilities with API in the back half of 2027 from Menlo Park. Can't really rush this. They might be able to shave off a month or two because of some things already being setup within the facility, but I couldn't tell you to what extent.
0 · Reply
WallStreetBulll
WallStreetBulll Jul. 3 at 9:55 PM
Need a supply squeeze for $HIMS to keep the tape running. If shorts get trapped, this name can keep ripping higher.
0 · Reply
MarketMaestro1
MarketMaestro1 Jul. 3 at 9:38 PM
In the past year: Biggest Gains: $HIMS +110% $OSCR +190% $AMD +380% $ASTS +440% My biggest losers (unrealised)*: $ETH.X -28% Looking to focus on the names setting up in good groups.. Next week’s portfolio and watchlist are live! Head back to my profile to get the latest trading strategies and market analysis.
0 · Reply
AIWealthCircle
AIWealthCircle Jul. 3 at 8:52 PM
🚨 $HIMS Now hiring peptide API engineers and management at its peptide manufacturing facility in Menlo Park, California. This is not just expansion this is vertical integration in real time. Hims is clearly signaling a push toward owning the full stack of peptide production: from API manufacturing all the way through distribution. That kind of strategy changes the margin profile and control over supply chain entirely. If executed properly, this is how companies move from “product layer” players into infrastructure-level healthcare platforms. Today, there are a few more hated names where we’re showing the same conviction And I think history could repeat itself Do you want the list?
0 · Reply
SocialYoutube
SocialYoutube Jul. 3 at 6:17 PM
$HIMS What the new hirings actually mean! The Menlo Park facility has the capability of somewhere between 10-50kg of API production per year. It's a stepping stone. You figure things out there, and then expand into a more manufacturing-friendly area like Ohio or Florida. Just like we did with Apostrophe. 10-50kg of API will suffice 100k-500k patients. If you sell a peptide for $150, this facility has the ability to increase margins on a maximum of 900 million of revenue per year. The API cost for peptides makes up about 50% of manufacturing cost : ) Treat this as a small step. What you should get really excited for is expansion, or dare I say, maybe even becoming a supplier of API for the US market in the distant future. Now...Go celebrate our 250th. We're not a perfect nation. We've got a lot of things wrong. But as a whole, we've got more things right. Be proud of where you come from.
0 · Reply
Latest News on HIMS
Hims & Hers price target raised to $39 from $29 at Barclays

2026-06-17T18:55:42.000Z - 16 days ago

Hims & Hers price target raised to $39 from $29 at Barclays

NVO


Hims & Hers Health Transcript: AGM 2026

Jun 11, 2026, 2:00 PM EDT - 23 days ago

Hims & Hers Health Transcript: AGM 2026


Hims & Hers Health Slides: Investor presentation

May 28, 2026, 7:00 AM EDT - 5 weeks ago

Hims & Hers Health Slides: Investor presentation


Hims & Hers Drops After Earnings Miss & HIMS Options Trade

May 12, 2026, 11:30 AM EDT - 7 weeks ago

Hims & Hers Drops After Earnings Miss & HIMS Options Trade


Hims & Hers Health Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 7 weeks ago

Hims & Hers Health Earnings Call Transcript: Q1 2026


Hims & Hers Health Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 7 weeks ago

Hims & Hers Health Slides: Q1 2026


Hims & Hers Health Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 7 weeks ago

Hims & Hers Health Earnings release: Q1 2026


Hims & Hers Health Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 7 weeks ago

Hims & Hers Health Quarterly report: Q1 2026


Hims & Hers Health Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 2 months ago

Hims & Hers Health Proxy statement: Proxy filing


Hims & Hers Health Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 2 months ago

Hims & Hers Health Proxy statement: Proxy filing


Hims & Hers surges 4% as peptide policy shift unlocks growth

Apr 16, 2026, 10:42 AM EDT - 2 months ago

Hims & Hers surges 4% as peptide policy shift unlocks growth


Novo Nordisk's FDA-Approved GLP-1s Now Available With Hims & Hers

Mar 26, 2026, 12:00 PM EDT - 3 months ago

Novo Nordisk's FDA-Approved GLP-1s Now Available With Hims & Hers


Hims & Hers Names Kathryn Beiser as Chief Communications Officer

Mar 10, 2026, 8:08 PM EDT - 4 months ago

Hims & Hers Names Kathryn Beiser as Chief Communications Officer


HIMS Skyrockets on Reported Deal with NVO to Sell GLP-1s

Mar 9, 2026, 11:00 AM EDT - 4 months ago

HIMS Skyrockets on Reported Deal with NVO to Sell GLP-1s

NVO


Novo Nordisk drops Him & Hers lawsuit

Mar 9, 2026, 10:38 AM EDT - 4 months ago

Novo Nordisk drops Him & Hers lawsuit

NVO


Hims stock jumps 50% as Novo Nordisk ends lawsuit, strikes deal

Mar 9, 2026, 9:23 AM EDT - 4 months ago

Hims stock jumps 50% as Novo Nordisk ends lawsuit, strikes deal


What's Happening With HIMS Stock?

Mar 9, 2026, 8:35 AM EDT - 4 months ago

What's Happening With HIMS Stock?


JD101
JD101 Jul. 4 at 6:34 PM
0 · Reply
inquisitive1
inquisitive1 Jul. 4 at 6:12 PM
$HIMS Arrie, thanks for clarifying German market. We shall see what Monday brings here in the U.S.
0 · Reply
stockro1
stockro1 Jul. 4 at 2:28 PM
$IXHL The market has a habit of mispricing companies when the story changes faster than the valuation. I think that’s happening here. • Targeting one of the world’s largest unmet medical markets (Obstructive Sleep Apnoea) • Positive Phase 2 efficacy • Strong balance sheet, minimal debt • Multiple catalysts ahead • Small share count • Valuation that still looks modest if development succeeds This is now an execution story. Today’s valuation appears to price in far more failure than success. Watching for: ✔️ First patient dosed ✔️ Clinical progress ✔️ Institutional buying ✔️ Strategic partnerships The biggest gains often come before consensus catches up. Do your own research. $IXHL $VKTX $ALT $HIMS $LLY
3 · Reply
Arrie1982
Arrie1982 Jul. 4 at 11:36 AM
$HIMS this means 39 in usd, strong day in Europe 👌
0 · Reply
shwesdawg
shwesdawg Jul. 4 at 4:58 AM
$HIMS bodega by my house is selling peptides now 😂😂😂
1 · Reply
SocialYoutube
SocialYoutube Jul. 3 at 10:25 PM
$HIMS Been reading up on the cGMP validation process. You need to produce 3 consecutive batches (3-5 weeks per batch) and everything from software, hardware, ventilation, sensors, product, purity, safety, and data --- nothing can go wrong or you start all over. Then you have to wait to make sure that your product doesn't degrade while being stored over 1 month, 3 month, and 6 month time spans. Hims should be on track to supply their own compounding facilities with API in the back half of 2027 from Menlo Park. Can't really rush this. They might be able to shave off a month or two because of some things already being setup within the facility, but I couldn't tell you to what extent.
0 · Reply
WallStreetBulll
WallStreetBulll Jul. 3 at 9:55 PM
Need a supply squeeze for $HIMS to keep the tape running. If shorts get trapped, this name can keep ripping higher.
0 · Reply
MarketMaestro1
MarketMaestro1 Jul. 3 at 9:38 PM
In the past year: Biggest Gains: $HIMS +110% $OSCR +190% $AMD +380% $ASTS +440% My biggest losers (unrealised)*: $ETH.X -28% Looking to focus on the names setting up in good groups.. Next week’s portfolio and watchlist are live! Head back to my profile to get the latest trading strategies and market analysis.
0 · Reply
AIWealthCircle
AIWealthCircle Jul. 3 at 8:52 PM
🚨 $HIMS Now hiring peptide API engineers and management at its peptide manufacturing facility in Menlo Park, California. This is not just expansion this is vertical integration in real time. Hims is clearly signaling a push toward owning the full stack of peptide production: from API manufacturing all the way through distribution. That kind of strategy changes the margin profile and control over supply chain entirely. If executed properly, this is how companies move from “product layer” players into infrastructure-level healthcare platforms. Today, there are a few more hated names where we’re showing the same conviction And I think history could repeat itself Do you want the list?
0 · Reply
SocialYoutube
SocialYoutube Jul. 3 at 6:17 PM
$HIMS What the new hirings actually mean! The Menlo Park facility has the capability of somewhere between 10-50kg of API production per year. It's a stepping stone. You figure things out there, and then expand into a more manufacturing-friendly area like Ohio or Florida. Just like we did with Apostrophe. 10-50kg of API will suffice 100k-500k patients. If you sell a peptide for $150, this facility has the ability to increase margins on a maximum of 900 million of revenue per year. The API cost for peptides makes up about 50% of manufacturing cost : ) Treat this as a small step. What you should get really excited for is expansion, or dare I say, maybe even becoming a supplier of API for the US market in the distant future. Now...Go celebrate our 250th. We're not a perfect nation. We've got a lot of things wrong. But as a whole, we've got more things right. Be proud of where you come from.
0 · Reply
gunitfifty
gunitfifty Jul. 3 at 5:53 PM
$SPY follow me if you want to make $$$$ I’m not undefeated however my biggest shorts and longs always play out in my favor. Going to beat down $HIMS again because he hires victims and pedos
0 · Reply
inquisitive1
inquisitive1 Jul. 3 at 4:48 PM
$HIMS bulli, thanks for sharing. Are the stock prices on the German market the same as on the American market?
1 · Reply
bullishoverbears
bullishoverbears Jul. 3 at 3:58 PM
$HIMS closed in german market @ $39.22
1 · Reply
ZenInvestor3
ZenInvestor3 Jul. 3 at 3:23 PM
$HIMS 90pps by EOY?
1 · Reply
AIWealthCircle
AIWealthCircle Jul. 3 at 2:34 PM
$HIMS (monthly) This is starting to show a very constructive long-term structure. The reversal from the $14 area was strong, and price has not meaningfully looked back since. That kind of sustained momentum usually signals that buyers have taken full control of the higher timeframe trend. More importantly, we’ve now broken above a major resistance zone, which has flipped into a support area between roughly $28$32 (blue zone). That flip is critical it turns previous supply into demand. From a monthly perspective, as long as this support zone continues to hold and defend, the broader path toward $70 remains technically open. Today, there are a few more hated names where we're showing the same conviction And I think history could repeat itself Do you want the list? Head back to my profile to get the latest trading strategies and market analysis.
1 · Reply
JD101
JD101 Jul. 3 at 2:24 PM
$HIMS fibs point to $120 area
0 · Reply
noyb1123
noyb1123 Jul. 3 at 10:02 AM
$HIMS You have great insight!
0 · Reply
Wolfeyetrader7
Wolfeyetrader7 Jul. 3 at 7:39 AM
$HIMS he is here at their door step now a short squeeze is upon us $50+ very soon
1 · Reply
mantegnous
mantegnous Jul. 3 at 7:12 AM
$HIMS come on buddy, beautiful chart! I rise the target, 50+ EOY
0 · Reply
Kenan123
Kenan123 Jul. 3 at 6:18 AM
$ADUR $HIMS $SOFI Happy Fourth of July!
0 · Reply
CrazyJuice
CrazyJuice Jul. 2 at 8:58 PM
$HIMS pop into the close says it all. Cya Monday. Happy 4th yall!!
0 · Reply
badekt22
badekt22 Jul. 2 at 8:12 PM
$HIMS fucking scammers
0 · Reply